Literature DB >> 11153966

Childhood and adolescent predictors of schizophrenia in the Northern Finland 1966 birth cohort--a descriptive life-span model.

M Isohanni1, P Jones, L Kemppainen, T Croudace, I Isohanni, J Veijola, S Räsänen, K E Wahlberg, P Tienari, P Rantakallio.   

Abstract

Subtle motor, emotional, cognitive and behavioral abnormalities are often present in apparently healthy children and adolescents who later develop schizophrenia. This suggests that some aspects of causation are established long before psychosis is manifest. We aim to develop a descriptive model of the factors contributing to the development of schizophrenia. Our main focus is on genetic factors, pregnancy and delivery complications, early development and scholastic performance. This is done by reviewing the Northern Finland 1966 Birth Cohort, its scientific activities (publications and work in progress) and selected literature.

Entities:  

Mesh:

Year:  2000        PMID: 11153966     DOI: 10.1007/s004060070006

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  12 in total

1.  Long-term psychosocial effects of parental divorce: a follow-up study from adolescence to adulthood.

Authors:  Taina Huurre; Hanna Junkkari; Hillevi Aro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-03-06       Impact factor: 5.270

2.  Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited.

Authors:  Judith Rapoport; Alex Chavez; Deanna Greenstein; Anjene Addington; Nitin Gogtay
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-01       Impact factor: 8.829

3.  Dimensional assessment of schizotypal, psychotic, and other psychiatric traits in children and their parents: development and validation of the Childhood Oxford-Liverpool Inventory of Feelings and Experiences on a representative US sample.

Authors:  David W Evans; Laina G Lusk; Mylissa M Slane; Andrew M Michael; Scott M Myers; Mirko Uljarević; Oliver Mason; Gordon Claridge; Thomas Frazier
Journal:  J Child Psychol Psychiatry       Date:  2017-10-30       Impact factor: 8.982

Review 4.  The complement system in schizophrenia.

Authors:  Karine R Mayilyan; Daniel R Weinberger; Robert B Sim
Journal:  Drug News Perspect       Date:  2008-05

5.  Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders.

Authors:  Moogeh Baharnoori; Sanjeev K Bhardwaj; Lalit K Srivastava
Journal:  Schizophr Bull       Date:  2010-08-30       Impact factor: 9.306

Review 6.  Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders.

Authors:  Cynthia M Schumann; Melissa D Bauman; David G Amaral
Journal:  Neuropsychologia       Date:  2010-10-13       Impact factor: 3.139

Review 7.  Developmental precursors of psychosis.

Authors:  Matti Isohanni; Irene Isohanni; Hannu Koponen; Johanna Koskinen; Pekka Laine; Erika Lauronen; Jouko Miettunen; Pirjo Mäki; Kaisa Riala; Sami Räsänen; Kaisa Saari; Pekka Tienari; Juha Veijola; Graham Murray
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

8.  Parental psychiatric disorders and autism spectrum disorders.

Authors:  Elina Jokiranta; Alan S Brown; Markus Heinimaa; Keely Cheslack-Postava; Auli Suominen; Andre Sourander
Journal:  Psychiatry Res       Date:  2013-02-04       Impact factor: 3.222

9.  The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment.

Authors:  Noah J Sasson; Amy E Pinkham; Kimberly L H Carpenter; Aysenil Belger
Journal:  J Neurodev Disord       Date:  2010-12-16       Impact factor: 4.025

10.  Maternal depression and anxiety predicts the pattern of offspring symptoms during their transition to adulthood.

Authors:  H Gonçalves; R M Pearson; B L Horta; D A González-Chica; E Castilho; M Damiani; R C Lima; D P Gigante; F C Barros; A Stein; C G Victora
Journal:  Psychol Med       Date:  2015-10-12       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.